MTOR and neoplasm: A previous study of CX-5461 on human OS in vitro found that CX-5461 induced anti-tumour activity via the activation of autophagy involving the mammalian target of rapamycin (mTOR) signalling pathways in the OS cell lines U-2-OS and MNNG/HOS [32].